Informations générales (source: ClinicalTrials.gov)
Optimize the Support of Patients in Pelvic Onco-gynecology Through Adapted Support Care in the Post-cancer Period. AFTERGYN Pilot Phase (AFTERGYN)
Interventional
N/A
Centre Francois Baclesse (Voir sur ClinicalTrials)
janvier 2023
juillet 2025
13 août 2024
While the sequelae and toxicities after ovarian and endometrial cancer treatments are
well described in the literature, the actual needs of patients for supportive oncology
care remain poorly documented. Moreover, there is no data available to estimate the
complexity of the oncological support care actions to be implemented.
It is expected that an evaluation of the needs for supportive oncology care and its
organization in day hospitalization for supportive oncology care will lead to an
improvement in personalized post-cancer follow-up for these patients and to an
improvement in their long-term quality of life.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CLCC RENE HUGUENIN INSTITUT CURIE | 04/12/2024 12:43:59 | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Centre Francois Baclesse - 14076 - Caen - France | GERNIER Francois | Contact (sur clinicalTrials) | |||
Critères
Femme
Inclusion Criteria:
- Patient > 18 years old
- Patient in complete remission after first-line treatment for endometrial or
ovarian/fallopian tube/peritoneal cancer
- Patient having completed her initial treatment; patients with maintenance treatments
are eligible
- Mastery of the French language
- Patient with a telephone line
- Patient affiliated to a social security scheme
- Signature of informed consent before any specific procedure related to the study
- Patient > 18 years old
- Patient in complete remission after first-line treatment for endometrial or
ovarian/fallopian tube/peritoneal cancer
- Patient having completed her initial treatment; patients with maintenance treatments
are eligible
- Mastery of the French language
- Patient with a telephone line
- Patient affiliated to a social security scheme
- Signature of informed consent before any specific procedure related to the study
- Any associated medical or psychiatric conditions that could compromise the patient's
ability to participate in the study
- Patient with locoregional or metastatic recurrence
- Patient deprived of liberty, under guardianship or curatorship
- Simultaneous participation in a therapeutic clinical trial